Cell Care Australia Pty Ltd - proposed acquisition of cord blood and tissue banking assets of Cryosite Limited

Acquirer(s)

  • Cell Care Australia Pty Ltd

Target(s)

  • Cryosite Limited

Summary

The ACCC has decided that it will not make a decision on whether to grant clearance for the proposed acquisition under section 50 of the Competition and Consumer Act (CCA), and will discontinue its public review of the proposed acquisition. The ACCC is continuing to investigate the circumstances surrounding entry into the agreement and the closing of Cryosite?s cord blood and tissue collection operations

Timeline

DateEvent
18/09/2017ACCC commenced review under the Merger Process Guidelines.
13/10/2017Closing date for submissions from interested parties.
24/10/2017ACCC requested further information from Cryosite Limited.
01/11/2017ACCC received further information from Cell Care Australia Pty Ltd.
03/11/2017ACCC is awaiting information from Cryosite Limited and Cell Care Australia Pty Ltd. Former provisional date for announcement of ACCC's findings (16 November) is delayed. ACCC will announce a proposed decision date in due course.
21/12/2017After considering the information available to it, the ACCC has decided that it will not make a decision on whether to grant clearance for the proposed acquisition under section 50 of the Competition and Consumer Act (CCA), and will discontinue its public review of the proposed acquisition.